INHIBITION OF THE NKG2D ACTIVATING RECEPTOR EXPRESSION ON CYTOTOXIC LYMPHOCYTES BY RECOMBINANT MICA PROTEIN
Genome instability of transformed cells, being the most common factor of malignancy, may result into production of abnormal proteins in these cells. Normally, the newly formed proteins are recognized by immune system, thus causing elimination of the transformed cells. Nevertheless, the phenotypic in...
Main Authors: | E. V. Abakushina, E. Yu. Lyssuk, A. V. Posvyatenko, A. V. Kibardin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2017-01-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/1168 |
Similar Items
-
POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE
by: E. A. Shulenina, et al.
Published: (2017-08-01) -
NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications
by: Jagoda Siemaszko, et al.
Published: (2021-06-01) -
MICA-specific nanobodies for diagnosis and immunotherapy of MICA+ tumors
by: Elisha R. Verhaar, et al.
Published: (2024-03-01) -
The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
by: Ge Tan, et al.
Published: (2023-08-01) -
KLF4-mediated upregulation of the NKG2D ligand MICA in acute myeloid leukemia: a novel therapeutic target identified by enChIP
by: Reem Alkhayer, et al.
Published: (2023-05-01)